Mild cognitive impairment (MCI) is a condition between normal aging and Alzheimer's disease (AD), with around 12% of individuals progressing to AD each year. Understanding how cognitive functions evolve over time in people with MCI, especially those who eventually develop AD, is key to improving early detection and intervention.
Objective
To investigate the longitudinal changes in the relationships between cognitive functions in patients with MCI, which will or will not convert to AD.
Methods
We applied cross-lagged panel network (CLPN) to data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We analyzed cognitive evaluations over two years in 128 converters to AD (convMCI), 390 non-converters (stabMCI), and 362 healthy participants (HP).
Results
HP and stabMCI showed increasing stability in their performance over time (i.e., a performance at one time predicting the same performance at a later point), while convMCI experienced a decline. Additionally, while HP maintained stable relationships between different tests (i.e., a performance at one time predicting a different performance at a later point), individuals with MCI showed more fluctuation, particularly those who progress to AD. We also found that executive functions were the most reliable predictors of future cognition in healthy participants, while memory played a more critical role in predicting outcomes for MCI patients, especially those who convert to dementia.
Conclusions
These findings highlight different cognitive trajectories in MCI patients, offering valuable insights into how cognitive decline unfolds in those at risk of developing dementia. Our results shed new light on the longitudinal reorganization of cognitive performances.
NicholsESteinmetzJDVollsetSE, et al.Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health2022; 7: e105–e125.
2.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med2004; 256: 183–194.
3.
PetersenRCMorrisJC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol2005; 62: 1160–1163.
SmithBOwnbyRL. Disease-modifying treatments and their future in Alzheimer’s disease management. Cureus2024; 16: e56105.
6.
AmjadHRothDLSheehanOC, et al.Underdiagnosis of dementia: an observational study of patterns in diagnosis and awareness in US older adults. J Gen Intern Med2018; 33: 1131–1138.
7.
Van Der MaasHLJDolanCVGrasmanRPPP, et al.A dynamical model of general intelligence: the positive manifold of intelligence by mutualism. Psychol Rev2006; 113: 842–861.
8.
FergusonC. A network psychometric approach to neurocognition in early Alzheimer’s disease. Cortex2021; 137: 61–73.
9.
TosiGBorsaniCCastiglioniS, et al.Complexity in neuropsychological assessments of cognitive impairment: a network analysis approach. Cortex2020; 124: 85–96.
10.
De NooyWMrvarABatageljV. Exploratory social network analysis with Pajek: Revised and expanded edition for updated software. 3rd edn. Cambridge: Cambridge University Press, 2018.
11.
BorsboomDDesernoMKRhemtullaM, et al.Network analysis of multivariate data in psychological science. Nat Rev Methods Primer2021; 1: 58.
12.
BorsboomDDesernoMKRhemtullaM, et al.Author correction: network analysis of multivariate data in psychological science. Nat Rev Methods Primer2022; 2: 10.
13.
WeintraubSWicklundAHSalmonDP. The neuropsychological profile of Alzheimer disease. Cold Spring Harb Perspect Med2012; 2: a006171.
14.
TosiGNigroSUrsoD, et al.The network structure of cognitive impairment: from subjective cognitive decline to Alzheimer’s disease. J Neurosci2024; 44: e1344232023.
15.
WysockiAMcCarthyIvan BorkR, et al.Cross-lagged network models. Adv Psychol2025; 2: e739621.
16.
FolsteinMFolsteinSMcHughP. Mini-Mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res1975; 12: 189–198.
17.
MorrisJCHeymanAMohsRC, et al.The consortium to establish a registry for Alzheimer’s disease (CERAD). part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology1989; 39: 1159–1165.
18.
Rey André. L’examen clinique en psychologie. 2e éd. Paris: Presses universitaires de France, 1964.
ReitanRM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills1958; 8: 271–276.
23.
ReitanRMWolfsonD. The Halstead–Reitan Neuropsychological Test Battery: Research findings and clinical application. In: Specific learning disabilities and difficulties in children and adolescents: psychological assessment and evaluation. New York, NY: Cambridge University Press, 2001, pp.309–346.
24.
SpreenOStraussE. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press, 1998.
25.
GenoliniCMFalissardB. Kml: a package to cluster longitudinal data. Comput Methods Programs Biomed2011; 104: e112–e121.
26.
GenoliniCEcochardRJacqmin-GaddaH. Copy mean: a new method to impute intermittent missing values in longitudinal studies. Open J Stat2013; 03: 26–40.
27.
GenoliniCMFalissardB. Kml: k-means for longitudinal data. Comput Stat2010; 25: 317–328.
28.
FriedmanJHastieTTibshiraniR. Regularization paths for generalized linear models via coordinate descent. J Stat Softw2010; 33: 1–22.
29.
RosseelY. Lavaan: an R package for structural equation modeling. J Stat Softw2012; 48: 1–36.
30.
EpskampSCramerAOJWaldorpLJ, et al.Qgraph: network visualizations of relationships in psychometric data. J Stat Softw2012; 48: 1–18.
31.
GoswamiSMurthyCADasAK. Sparsity measure of a network graph: gini index. Inf Sci2018; 462: 16–39.
32.
AlbertMSDeKoskySTDicksonD, et al.The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement2011; 7: 270–279.
33.
Van Der MusseleSLe BastardNVermeirenY, et al.Behavioral symptoms in mild cognitive impairment as compared with Alzheimer’s disease and healthy older adults. Int J Geriatr Psychiatry2013; 28: 265–275.
34.
AschenbrennerAJHassenstabJMorrisJC, et al.Relationships between hourly cognitive variability and risk of Alzheimer disease revealed with mixed effects location scale models. Neuropsychology2024; 38: 69–80.
35.
CerinoESKatzMJWangC, et al.Variability in cognitive performance on mobile devices is sensitive to mild cognitive impairment: results from the Einstein Aging Study. Front Digit Health2021; 3: 758031.
36.
DixonRAGarrettDDLentzTL, et al.Neurocognitive markers of cognitive impairment: exploring the roles of speed and inconsistency. Neuropsychology2007; 21: 381–399.
37.
GogaJJGinellKMNgYT, et al.Feasibility, reliability, and validity of ambulatory smartphone-administered cognitive tests in multiple sclerosis. Mult Scler J2025; 31: 363–375.
38.
SliwinskiMJMogleJAHyunJ, et al.Reliability and validity of ambulatory cognitive assessments. Assessment2018; 25: 14–30.
39.
WilksHAschenbrennerAJGordonBA, et al.Sharper in the morning: cognitive time of day effects revealed with high-frequency smartphone testing. J Clin Exp Neuropsychol2021; 43: 825–837.
40.
DickersonBCSperlingRAHymanBT, et al.Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. Arch Gen Psychiatry2007; 64: 1443–1450.
41.
ParienteJColeSHensonR, et al.Alzheimer’s patients engage an alternative network during a memory task. Ann Neurol2005; 58: 870–879.
42.
StussDTMurphyKJBinnsMA, et al.Staying on the job: the frontal lobes control individual performance variability. Brain J Neurol2003; 126: 2363–2380.
43.
BangenKJWeigandAJThomasKR, et al.Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults. Neuropsychology2019; 33: 599–608.
44.
MurthaSCismaruRWaechterR, et al.Increased variability accompanies frontal lobe damage in dementia. J Int Neuropsychol Soc2002; 8: 360–372.
45.
LövdénMSchmiedekFKennedyKM, et al.Does variability in cognitive performance correlate with frontal brain volume?Neuroimage2013; 64: 209–215.
46.
HoltzerRVergheseJWangC, et al.Within-person across-neuropsychological test variability and incident dementia. JAMA2008; 300: 823–830.
47.
Malek-AhmadiMLuSChanY, et al.Cognitive domain dispersion association with Alzheimer’s disease pathology. J Alzheimers Dis2017; 58: 575–583.
48.
ChristensenHMackinnonAJKortenAE, et al.Dispersion in cognitive ability as a function of age: a longitudinal study of an elderly community sample. Aging Neuropsychol Cogn1999; 6: 214–228.
49.
AggarwalNTWilsonRSBeckTL, et al.Mild cognitive impairment in different functional domains and incident Alzheimer’s disease. J Neurol Neurosurg Psychiatry2005; 76: 1479–1484.
50.
BellevilleSFouquetCHudonC, et al.Neuropsychological measures that predict progression from mild cognitive impairment to Alzheimer’s type dementia in older adults: a systematic review and meta-analysis. Neuropsychol Rev2017; 27: 328–353.
51.
TabertMHManlyJJLiuX, et al.Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry2006; 63: 916–924.
52.
MyersCKlugerAGolombJ, et al.Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly. J Geriatr Psychiatry Neurol2008; 21: 103–193.
53.
StrangeBZhangLSierra-MarcosA, et al.Predicting the future development of mild cognitive impairment in the cognitively healthy elderly. bioRxiv 2020; DOI: 10.1101/2020.07.30.227496 [Preprint]. Posted July 31, 2020.
54.
CorboICasagrandeM. Higher-level executive functions in healthy elderly and mild cognitive impairment: a systematic review. J Clin Med2022; 11: 1204.
55.
VerrecktEGrimmEAgrigoroaeiS, et al.Investigating the relationship between specific executive functions and functional decline among community-dwelling older adults: results from a prospective pilot study. BMC Geriatr2022; 22: 976.
56.
FergusonCEFoleyJA. The influence of working memory and processing speed on other aspects of cognitive functioning in de novo Parkinson’s disease: initial findings from network modelling and graph theory. J Neuropsychol2024; 18: 136–153.
57.
BernierPJGourdeauCCarmichaelP-H, et al.It’s all about cognitive trajectory: accuracy of the cognitive charts–MoCA in normal aging, MCI, and dementia. J Am Geriatr Soc2023; 71: 214–220.
58.
VeronelliLTosiGRomanoD. Modeling functional loss in Alzheimer’s disease through cognitive reserve and cognitive state: a panel data longitudinal study. Neurobiol Aging2025; 147: 60–67.
59.
BernierPJGourdeauCCarmichaelP-H, et al.Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults. CMAJ Can Med Assoc J2017; 189: E1472–E1480.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
